PDB22 EVALUATING THE LONG-TERM HEALTH OUTCOMES AND ECONOMICS OF INITIATING BIPHASIC ANALOG INSULIN COMPARED TO OPTIMIZED ORAL THERAPY ALONE
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63292-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)63292-5/fulltext
Section Title :
Section Order :
143
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63292-5&doi=10.1016/S1098-3015(10)63292-5